Works matching IS 1178-6930 AND VI 14 AND DT 2021

Results: 525

Promotion of miR-221-5p on the Sensitivity of Gastric Cancer Cells to Cisplatin and Its Effects on Cell Proliferation and Apoptosis by Regulating DDR1 [Retraction].

Published in:

2021

By:

Jiang, Xiaomeng;
Jiang, Menglin;
Guo, Shuhua;
Cai, Pengpeng;
Wang, Wei;
Li, Yi

Publication type:

Correction Notice

LncRNA SNHG16 Regulates the Progress of Acute Myeloid Leukemia Through miR183-5p–FOXO1 Axis [Retraction].

Published in:

2021

By:

Yang, Ru;
Ma, Dong;
Wu, Yanwei;
Zhang, Yingzi;
Zhang, Lina

Publication type:

Correction Notice

Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5507, doi. 10.2147/OTT.S303060

By:

Vitale, Candida;
Gibbons, Jamie Lynn;
Ferrajoli, Alessandra

Publication type:

Article

Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis [Retraction].

Published in:

2021

By:

Zhu, Zhixiang;
Shen, Songhe;
Zhao, Sen;
Wang, Zhixue

Publication type:

Correction Notice

Efficacy and Drug Resistance Analysis of ALK Inhibitors in Combination with Stereotactic Body Radiation Therapy for Treating Lung Squamous Carcinoma Patient Harboring EML4-ALK Rearrangement.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5385, doi. 10.2147/OTT.S335736

By:

Liang, Long;
Mao, Mian;
Wu, Lei;
Chen, Taiyu;
Lyu, Jiahua;
Wang, Qifeng;
Li, Tao

Publication type:

Article

CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5477, doi. 10.2147/OTT.S325203

By:

Yang, Yanlong;
Hu, Zaoxiu;
Sun, Hongwen;
Yu, Qinghe;
Yang, Linzhu;
Yin, Fang;
Sun, Yongmen;
Pu, Lisha;
Zhu, Xingming;
Li, Shen;
Chen, Xiaobo;
Zhao, Yunping

Publication type:

Article

Endostar Plus Apatinib Successfully Achieved Long Term Progression-Free Survival in Refractory Ovarian Cancer: A Case Report and Literature Review.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5363, doi. 10.2147/OTT.S335139

By:

Xiao, Chunmei;
Xu, Fangye;
Wang, Rong;
Liang, Qi;
Shen, Kai;
Xu, Jiali;
Liu, Lianke

Publication type:

Article

Overexpressed Long Noncoding RNA TUG1 Affects the Cell Cycle, Proliferation, and Apoptosis of Pancreatic Cancer Partly Through Suppressing RND3 and MT2A [Retraction].

Published in:

2021

By:

Hui, Bingqing;
Xu, Yetao;
Zhao, Benpeng;
Ji, Hao;
Ma, Zhonghua;
Xu, Shufen;
He, ZhenYu;
Wang, Keming;
Lu, Jianwei

Publication type:

Correction Notice

Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment: A Report of Two Cases.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5447, doi. 10.2147/OTT.S333604

By:

Wu, Tong;
Zhang, Linzhi;
Zeng, Zhen;
Yan, Tao;
Cheng, Jiamin;
Miao, Xiaojie;
Lu, Yinying

Publication type:

Article

M2-Type Macrophages Induce Tregs Generation by Activating the TGF-β/Smad Signalling Pathway to Promote Colorectal Cancer Development.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5391, doi. 10.2147/OTT.S336548

By:

Ma, Xueqian;
Gao, Yu;
Chen, Yanlei;
Liu, Jinhao;
Yang, Chunyu;
Bao, Cuifen;
Wang, Yanping;
Feng, Yang;
Song, Xiaoyu;
Qiao, Shifeng

Publication type:

Article

Clinical Impact of Switching to Ceritinib After Severe AEs Related to Crizotinib/Alectinib in a Novel PTH2R-ALK Fusion Lung Adenocarcinoma: A Case Report.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5471, doi. 10.2147/OTT.S340984

By:

Shen, Gang;
Du, Yinping;
Shen, Jifang;
Zhang, Junling;
Xia, Xihua;
Huang, Mengli;
Shen, Wenxiang

Publication type:

Article

Clinical Evaluation of Ramucirumab for the Treatment of Hepatocellular Carcinoma (HCC): Place in Therapy.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5521, doi. 10.2147/OTT.S268309

By:

Choucair, Khalil;
Kamran, Syed;
Saeed, Anwaar

Publication type:

Article

Efficient Everolimus Treatment for Metastatic Castration Resistant Prostate Cancer with AKT1 Mutation: A Case Report.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5423, doi. 10.2147/OTT.S334205

By:

Yu, Zhe;
Wei, Wei;
Liu, Hongruo;
Pan, Evenki;
Yang, Peng;
Jiang, Kui

Publication type:

Article

Effective Disease Control After Combinatorial Treatment with a PD-1 Antibody and an mTOR Inhibitor for Recurrent Ovarian Clear Cell Carcinomas: A Case Report and Literature Review.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5429, doi. 10.2147/OTT.S333029

By:

Li, Yue;
Liu, wentao;
Yue, Xiaolong;
Fang, Yu;
Zhang, Xiaoyan;
Zhang, Xin;
He, Qifan;
Fu, Na;
Wang, Sizhen;
Ma, Tonghui;
Li, Dalin

Publication type:

Article

Identification of NUTF2 as a Candidate Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5455, doi. 10.2147/OTT.S337469

By:

Zhang, Rui;
Gao, Ying

Publication type:

Article

Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5373, doi. 10.2147/OTT.S342613

By:

Wang, Ning;
Liu, Dingsheng

Publication type:

Article

High Red Cell Distribution Width Independently Predicts Adverse Survival in Patients with Newly Diagnosed Skull Base Chordoma.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5435, doi. 10.2147/OTT.S335454

By:

Li, Mingxuan;
Shen, Yutao;
Xiong, Yujia;
Bai, Jiwei;
Wang, Shuai;
Li, Chuzhong;
Zhang, Yazhuo

Publication type:

Article

Fibrinogen/Albumin Ratio (FAR) in Patients with Triple Negative Breast Cancer and Its Relationship with Epidermal Growth Factor Receptor Expression.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5403, doi. 10.2147/OTT.S339973

By:

Gao, Wenbo;
Li, Ming;
Zhang, Yunhao

Publication type:

Article

Alectinib Together with Intracranial Therapies Improved Survival Outcomes in Untreated ALK-Positive Patients with Non-Small-Cell Lung Cancer and Symptomatic and Synchronic Brain Metastases: A Retrospective Study.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5533, doi. 10.2147/OTT.S345439

By:

Yin, Qiang;
Li, Peng;
Wang, Peng;
Zhang, Zhen;
Liu, Qun;
Sun, Zengfeng;
Li, Wenliang;
Ma, Li;
Wang, Xiaoguang

Publication type:

Article

AATF is Overexpressed in Human Bladder Cancer and Regulates Chemo-Sensitivity Through Survivin.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5493, doi. 10.2147/OTT.S319734

By:

Tan, Shutao;
Fu, Lin;
Dong, Qianze

Publication type:

Article

Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5321, doi. 10.2147/OTT.S273357

By:

Guo, Matthew Z;
Marrone, Kristen A;
Spira, Alexander;
Waterhouse, David M;
Scott, Susan C

Publication type:

Article

Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5333, doi. 10.2147/OTT.S350023

By:

Hu, Huanrong;
Dong, Zhen;
Wang, Xianxing;
Bai, Longchang;
Lei, Qian;
Yang, Jie;
Li, Lin;
Li, Qian;
Liu, Lichao;
Zhang, Yanli;
Ji, Yacong;
Guo, Leiyang;
Liu, Yaling;
Cui, Hongjuan

Publication type:

Article

Long-Term Survival After Salvage Thoracic Surgery on a Patient with ALK-Rearranged Metastatic Lung Adenocarcinoma After Progression on Targeted Therapy.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5221, doi. 10.2147/OTT.S325460

By:

Ren, Kangqi;
Ding, Guanggui;
Xie, Shuying;
Yang, Lin

Publication type:

Article

Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report.

Published in:

2021

By:

Kato, Yuki;
Kato, Yasuhiro;
Minegishi, Yuji;
Suzuki, Takahiro;
Nakamichi, Shinji;
Matsumoto, Masaru;
Miyanaga, Akihiko;
Noro, Rintaro;
Kubota, Kaoru;
Terasaki, Yasuhiro;
Seike, Masahiro;
Gemma, Akihiko

Publication type:

Case Study

The Study of Mucosal-Associated Invariant T Cells in Colon Cancer and Roles in Immune Activities.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5263, doi. 10.2147/OTT.S332822

By:

Mo, Juanfen;
Zheng, Li;
Gao, Zhenzhen;
Wu, Jiayuan;
Bao, Yi

Publication type:

Article

Immunotherapy-Related Cardiotoxicity Re-Emergence in Non-Small Cell Lung Cancer – A Case Report.

Published in:

2021

By:

Li, Yuanxiang;
Hu, Yang;
Yang, Bin;
Jin, Caibao;
Ren, Hui;
Wu, Jingyi;
Wang, Zhijun;
Wei, Youying;
Yang, Ling;
Hu, Yanping

Publication type:

Case Study

Anti-γ-Aminobutyric Acid Type β Receptor Antibody-Associated Encephalitis After 2 Cycles of Durvalumab Therapy in a Patient with Small Cell Lung Cancer: A Case Report.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5227, doi. 10.2147/OTT.S337331

By:

Li, Jiamo;
Jiang, Jianing;
Lv, Jinyan;
Zhang, Ru;
Chen, Wenting;
Li, Shiyi;
Jin, Qianchen;
Wang, Gang

Publication type:

Article

Circular RNA SMARCA5 Inhibits the Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer by miR-19b-3p/HOXA9 Axis [Retraction].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5261, doi. 10.2147/OTT.S348927

By:

Wang, Yaqiu;
Li, Huiping;
Lu, Hong;
Qin, Yaguang

Publication type:

Article

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5297, doi. 10.2147/OTT.S335217

By:

Gan, Jiadi;
Huang, Yihua;
Liao, Jun;
Pang, Lanlan;
Fang, Wenfeng

Publication type:

Article

Potential Biomarkers for the Efficacy of PD-1-PD-L Blockade in Cancer.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5275, doi. 10.2147/OTT.S283892

By:

Grecea, Miruna;
Soritau, Olga;
Dulf, Daniel;
Ciuleanu, Tudor Eliade;
Zdrenghea, Mihnea

Publication type:

Article

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5237, doi. 10.2147/OTT.S333134

By:

Fu, Lin;
Jin, Quanxiu;
Dong, Qianze;
Li, Qingchang

Publication type:

Article

Favorable Response to Olaparib in a Patient with Cancer of Unknown Primary Carrying a Germline BRCA1 R71K Mutation.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5353, doi. 10.2147/OTT.S334847

By:

Jia, Xiaomeng;
Zhao, Shanshan;
Li, Xiang;
Lv, Li;
Chen, Xin;
Pan, Evenki;
Ou, Qiuxiang;
Song, Chen;
Sun, Siwen;
Zhao, Jinbo;
Xu, Lingzhi;
Li, Man

Publication type:

Article

Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5345, doi. 10.2147/OTT.S325208

By:

del Carmen Álamo, Mª;
Ochenduszko, Sebastian;
Crespo, Guillermo;
Corral, Mónica;
Oramas, Juana;
Sancho, Pilar;
Medina, Javier;
Garicano, Fernando;
López, Pedro;
Balea, Begoña Campos;
Garzotto, Analia Rodríguez;
Muñoz-Couselo, Eva

Publication type:

Article

Cytochrome 4Z1 Expression is Associated with Poor Prognosis in Colon Cancer Patients.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5249, doi. 10.2147/OTT.S332037

By:

Al-saraireh, Yousef M;
Alshammari, Fatemah OFO;
youssef, Ahmed MM;
Al-Sarayreh, Sameeh;
Almuhaisen, Ghadeer H;
Alnawaiseh, Nedal;
Al-Shuneigat, Jehad M;
Alrawashdeh, Hamzeh M

Publication type:

Article

Overexpression of RNF126 Promotes the Development of Colorectal Cancer via Enhancing p53 Ubiquitination and Degradation [Corrigendum].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5293, doi. 10.2147/OTT.S348381

By:

Wang, Shiyang;
Wang, Tianlong;
Wang, Li;
Zhong, Liansheng;
Li, Kai

Publication type:

Article

Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer [Corrigendum].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5361, doi. 10.2147/ott.s318082

By:

Zhang, Qianqian;
Zong, Liju;
Zhang, Hui;
Xie, Wei;
Yang, Fan;
Sun, Wenwen;
Cui, Baoxia;
Zhang, Youzhong

Publication type:

Article

Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation [Corrigendum].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5295, doi. 10.2147/OTT.S348915

By:

Sun, Jiangang;
Shen, Dandan;
Gao, Yongshun;
Zheng, Yichao;
Zhao, Lijuan;
Maa, Mamum;
Liu, Hongmin;
Chen, Xiaoping

Publication type:

Article

TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4967, doi. 10.2147/OTT.S321949

By:

Yu, Ruili;
Sun, Tingyi;
Zhang, Xianwei;
Li, Zhen;
Xu, Yang;
Liu, Kaihua;
Shi, Yuqian;
Wu, Xue;
Shao, Yang;
Kong, Lingfei

Publication type:

Article

Correlation Between Thymoma and Soluble Interleukin-2 Receptor Expression in a Patient with Good Syndrome.

Published in:

2021

By:

Kitano, Haruka;
Yamaguchi, Fumihiro;
Atarashi, Kenji;
Hiraiwa, Mina;
Shiratori, Yo;
Onozaki, Shota;
Shikama, Yusuke

Publication type:

Case Study

The Controversial Role of Polyploidy in Hepatocellular Carcinoma.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5335, doi. 10.2147/OTT.S340435

By:

Wang, Nan;
Hao, Fengjie;
Shi, Yan;
Wang, Junqing

Publication type:

Article

MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4961, doi. 10.2147/OTT.S341745

By:

Li, Cuihong;
Yu, Shunrui;
Wu, Shanshan;
Ni, Ying;
Pan, Zixuan

Publication type:

Article

Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5145, doi. 10.2147/OTT.S272208

By:

Yu, James;
Mahipal, Amit;
Kim, Richard

Publication type:

Article

Efficacy and Toxicity Profile of Carfilzomib-Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4941, doi. 10.2147/OTT.S317570

By:

Imtiaz, Hassaan;
Khan, Maimoona;
Ehsan, Hamid;
Wahab, Ahsan;
Rafae, Abdul;
Khan, Ali Y;
Jamil, Abdur;
Sana, Muhammad Khawar;
Jamal, Abdullah;
Ali, Taimoor Jaffar;
Ansar, Iqraa;
Khan, Muzammil M;
Khouri, Jack;
Anwer, Faiz

Publication type:

Article

SNHG8 is Upregulated in Esophageal Squamous Cell Carcinoma and Directly Sponges microRNA-411 to Increase Oncogenicity by Upregulating KPNA2 [Retraction].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4993, doi. 10.2147/OTT.S341939

By:

Song, Huali;
Song, Jinxia;
Lu, Lianwei;
Li, Shoubo

Publication type:

Article

MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5001, doi. 10.2147/OTT.S341951

By:

Situ, Jie;
Zhang, Hao;
Jin, Zi;
Li, Ke;
Mao, Yunhua;
Huang, Wentao

Publication type:

Article

MicroRNA-937 Inhibits the Malignant Phenotypes of Breast Cancer by Directly Targeting and Downregulating Forkhead Box Q1 [Retraction].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4991, doi. 10.2147/OTT.S341741

By:

Han, Xiaoting;
Guo, Xiaolong;
Zhang, Wenzhen;
Cong, Qiumei

Publication type:

Article

RPARP-AS1/miR125a-5p Axis Promotes Cell Proliferation, Migration and Invasion in Colon Cancer.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5035, doi. 10.2147/OTT.S304494

By:

Ren, Yongjun;
Zhao, Caixia;
He, Yi;
Min, Xuli;
Xu, Hao;
Hu, Xiao

Publication type:

Article

MicroRNA-675 Directly Targets MAPK1 to Suppress the Oncogenicity of Papillary Thyroid Cancer and is Sponged by Long Non-Coding RNA RMRP [Retraction].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4995, doi. 10.2147/OTT.S341956

By:

Wang, Junyi;
Xiao, Tiantian;
Zhao, Ming

Publication type:

Article

MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1 [Retraction].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4965, doi. 10.2147/OTT.S341749

By:

Cheng, Kai;
Feng, Lan;
Yu, Shuang;
Yu, Changhong;
Chi, Nannan

Publication type:

Article

MicroRNA-618 Directly Targets Metadherin mRNA to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output [Retraction].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4963, doi. 10.2147/OTT.S341751

By:

Li, Bohan;
Zhao, Jie;
Zhao, Qian;
Wu, Dongjin;
Zhang, Cheng;
Zhao, Kun;
Song, Yang;
Gao, Chunzheng

Publication type:

Article